Brief: BeyondSpring Reports Data From Phase 1 Investigator Initiated Study Show Reduction In Chemotherapy-Induced Infectious Neutropenic Fever With Plinabulin
07/06/2023 13:19
June 7 (Reuters) - Beyondspring Inc BYSI.O :
* BEYONDSPRING INC - DATA FROM PHASE 1 INVESTIGATOR
INITIATED
STUDY SHOW REDUCTION IN CHEMOTHERAPY-INDUCED INFECTIOUS
NEUTROPENIC FEVER WITH PLINABULIN
* BEYONDSPRING INC - DATA FROM PHASE 1 STUDY WITH PLINABULIN
IN
COMBINATION WITH PEGFILGRASTIM IN MULTIPLE MYELOMA PATIENTS
Source text for Eikon: ID:nGNX5CZLlf
Further company coverage: BYSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beyondspring
See all newsBrief: Beyondspring Inc Entered Into Open Market Sale Agreement Under Which Co May Offer And Sell Up To 9.2 Million Ordinary Shares
Brief: Beyondspring Announces FDA Fast Track Designation For Plinabulin In Post-Ici Non-Squamous Nsclc And Strategic Transaction To Advance Global Phase 3 Dublin-4 Trial Toward Planned Interim Analysis
NASDAQ RESUMED AT 12:26 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:21 PM
Brief: Beyondspring Announces Leadership Transition To Deliver Focused Execution On Its Confirmatory Dublin-4 Program And Long-Term Value